Lato, Lina A.

HRN: 27-93-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/14/2025
CEFTAZIDIME 1GM (VIAL)
10/14/2025
10/21/2025
IV
2g
Q8h
CAP LR

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Non-compliant To Guidelines